Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2004 Jan 15;38(2):284-8. Epub 2003 Dec 22.

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.

Author information

  • 1Wayne State University, Detroit, Michigan 48201, USA. rmacarthur@med.wayne.edu

Abstract

As part of the Monoclonal Anti-TNF: A Randomized Controlled Sepsis (MONARCS) trial, which enrolled patients with suspected sepsis, we sought to determine whether adequate antibiotic therapy was associated with a decreased mortality rate. The study enrolled 2634 patients, 91% of whom received adequate antibiotic therapy. The mortality rate among patients given adequate antibiotic treatment was 33%, versus 43% among patients given inadequate treatment (P<.001). We conclude that adequate antibiotic therapy results in a significant decrease in the crude mortality rate among patients suspected of sepsis.

PMID:
14699463
DOI:
10.1086/379825
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center